Company: CERO
Filing Date: 2025-04-25
Form Type: PRE 14A
Source: 0001213900-25-035562
Chunk: 14

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-04-25
Form: PRE 14A
Chunk 14
---
 Proposal The proposal to approve an amendment to our Certificate of Incorporation to combine outstanding shares of our Common Stock into a lesser number of outstanding shares, by a ratio of not less than one -for- and not more than one -for- , with the exact ratio to be set within this range by our Board in its sole discretion, requires the approval by a majority of the votes properly cast for such matter. Abstentions will have no effect on the outcome of this proposal. As such proposal is a “routine” matter under NYSE rules, we do not expect any broker non -voteswith respect to such proposal. 4 Proposal No. 2 — Nasdaq Share Issuance (Warrants) Proposal The proposal to approve the issuance of shares of the Common Stock, pursuant to Nasdaq Listing Rule 5635, requires the approval by a majority of the votes properly cast for such matter. Abstentions and broker non -votes, if any, will have no effect on the outcome of this proposal. Proposal No. 3 — Nasdaq Share Issuance (Series D) Proposal The proposal to approve the issuance of shares of the Common Stock, pursuant to Nasdaq Listing Rule 5635, requires the approval by a majority of the votes properly cast for such matter. Abstentions and broker non -votes, if any, will have no effect on the outcome of this proposal. Proposal No. 4 — Plan Share Increase Proposal The proposal to approve the 2024 Plan, as amended, requires the approval by a majority of the votes properly cast for such matter. Abstentions and broker non -votes, if any, will have no effect on the outcome of this proposal. Proposal No. 5 — Director Election Proposal The proposal to approve the directors nominated for election requires the approval of plurality of votes properly cast for each director nominee. Abstentions and broker non -votes, if any, will have no effective on the outcome of this proposal. Proposal No. 6 — Auditor Ratification Proposal The proposal to ratify the auditors requires the approval by a majority of the votes cast on such matter. Abstentions will have no effect on the outcome of this proposal. As such proposal is a “routine” matter under NYSE rules, we do not expect any broker non -voteswith respect to such proposal. Proposal No. 7 — Adjournment Proposal The proposal to approve of an adjournment of the Annual Meeting requires the approval by a majority of the votes properly cast for such matter.